Correlation between chemotherapy response score (CRS) and germline BRCA1/2 (gBRCA) status in women diagnosed with FIGO stage IIIC/IV high-grade serous ovarian cancer (HGSOC)

被引：0
|
作者：
Netto, D. [1 ]
Wang, X. [2 ]
Barnes, B. [3 ]
Clamp, A. R. [1 ]
Hasan, J. [1 ]
Mitchell, C. L. [1 ]
Salih, Z. [1 ]
Winter-Roach, B. [4 ]
Edmondson, R. [3 ]
Shaw, J. [5 ]
Desai, S. [6 ]
Schlecht, H. [7 ]
Burghel, G. J. [8 ]
Taylor, S. [9 ]
Evans, G. [10 ]
Jayson, G. C. [11 ]
Morgan, R. D. [1 ]
机构：
[1] Christie NHS Fdn Trust, Med Oncol Dept, Manchester, Lancs, England
[2] Christie NHS Fdn Trust, Stat, Manchester, Lancs, England
[3] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[4] Christie NHS Fdn Trust, Surg Oncol, Manchester, Lancs, England
[5] Manchester Univ NHS Fdn Trust, Histopathol, Manchester, Lancs, England
[6] Christie NHS Fdn Trust, Pathol, Manchester, Lancs, England
[7] Manchester Univ NHS Fdn Trust, Genom, Wythenshawe Hosp, Manchester, Lancs, England
[8] GLH North West Genom Lab Hub, North West Genom Lab Hyb, Manchester, Lancs, England
[9] Univ Manchester, Manchester Canc Res Ctr, Manchester, Lancs, England
[10] Manchester Univ NHS Fdn Trust, Clin Genet, Manchester, Lancs, England
[11] Univ Manchester, Med Oncol, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1960
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
782P
引用
收藏
页码：S527 / S528
页数：2
相关论文
共 50 条
  • [41] Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancer
    McCuaig, Jeanna M.
    Stockley, Tracy L.
    Ferguson, Sarah E.
    Vicus, Danielle
    Brennenstuhl, Sarah
    Ott, Karen
    Kim, Raymond H.
    Metcalfe, Kelly A.
    JOURNAL OF GENETIC COUNSELING, 2023, 32 (02) : 503 - 513
  • [42] The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit
    Frugtniet, B.
    Morgan, S.
    Murray, A.
    Palmer-Smith, S.
    White, R.
    Jones, R.
    Hanna, L.
    Fuller, C.
    Hudson, E.
    Mullard, A.
    Quinton, A. E.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (03) : 433 - 442
  • [43] Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade serous or endometrioid ovarian cancer: A multi-national observational study
    Morgan, R. D.
    Clamp, A. R.
    Barnes, B.
    Schlecht, H.
    Yarram-Smith, L.
    Wallis, Y.
    Morgan, S.
    Valganon, M.
    Hudson, E.
    McKenna, S.
    Sundar, S.
    Nicum, S.
    Brenton, J. D.
    Kristeleit, R.
    Banerjee, S.
    McNeish, I.
    Ledermann, J. A.
    Taylor, S.
    Evans, G.
    Jayson, G. C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S810 - S810
  • [44] MOLECULAR LANDSCAPE IN HIGH-GRADE SEROUS OVARIAN CANCER: THE CORRELATION BETWEEN BRCA MUTATIONAL STATUS AND STROMAL P16 EXPRESSION
    Caretto, M.
    Pistolesi, S.
    Naccarato, A. G.
    Simoncini, T.
    Gadducci, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A338 - A338
  • [45] Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
    Launonen, I-M
    Lyytikainen, N.
    Casado, J.
    Anttila, E. A.
    Szabo, A.
    Haltia, U-M
    Jacobson, C. A.
    Lin, J. R.
    Maliga, Z.
    Howitt, B. E.
    Strickland, K. C.
    Santagata, S.
    Elias, K.
    D'Andrea, A. D.
    Konstantinopoulos, P. A.
    Sorger, P. K.
    Farkkila, A.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [46] Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
    I.-M. Launonen
    N. Lyytikäinen
    J. Casado
    E. A. Anttila
    A. Szabó
    U.-M. Haltia
    C. A. Jacobson
    J. R. Lin
    Z. Maliga
    B. E. Howitt
    K. C. Strickland
    S. Santagata
    K. Elias
    A. D. D’Andrea
    P. A. Konstantinopoulos
    P. K. Sorger
    A. Färkkilä
    Nature Communications, 13
  • [47] Homologous recombination (HR) deficiency, tumor BRCA1/2 mutations (tmBRCA) and association with response and outcome following platinum monotherapy in high grade serous ovarian cancer (HGSOC).
    Brown, Robert
    Timms, Kirsten
    Paul, James
    Hughes, Elisha
    El-Bahrawy, Mona
    Steel, Jennifer H.
    Kalva, Saritha
    Liu, Xinxue
    Wang, Yuepeng
    Rama, Nona R.
    Wilhelm-Benartzi, Charlotte
    Gutin, Alexander
    Lewsley, Liz-Anne
    Siddiqui, Nadeem
    Patel, Naina
    Lanchbury, Jerry S.
    Gabra, Hani
    Stronach, Euan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Small-scale variants and large deletions in BRCA1/2 genes in Slovak high-grade serous ovarian cancer
    Janikova, Katarina
    Vanova, Barbora
    Grendar, Marian
    Samec, Marek
    Loderer, Dusan
    Skerenova, Maria
    Kasubova, Ivana
    Farkasova, Anna
    Scheerova, Karla
    Slavik, Pavol
    Lasabova, Zora
    Dankova, Zuzana
    Strnadel, Jan
    Halasova, Erika
    Plank, Lukas
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 246
  • [49] INFLUENCE OF PREDICTIVE FEATURES ON THERAPY RESPONSE AND SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER PATIENTS BY GERMLINE BRCA MUTATION STATUS: AN UPDATE FROM THE AUSTRALIAN OVARIAN CANCER STUDY
    Zwimpfer, Tibor A.
    Fereday, Sian
    Ariyaratne, Dinuka
    Twomey, Laura
    Traficante, Nadia
    Goode, Ellen L.
    Defazio, Anna
    Bowtell, David D. L.
    Garsed, Dale W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A36 - A36
  • [50] Evaluation of a centralised national telephone genetic counselling service that facilitates BRCA1/2 testing for women with recurrent high-grade serous ovarian cancer
    Forrest, L. E.
    McKinley, J.
    Shepherd, R. Forbes
    Rasmussen, V.
    James, P. A.
    Meiser, B.
    Young, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 715 - 716
12345